Aktie 910678 PROGENICS PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Progenics Pharmaceuticals, Inc.

Aktien

910678

US7431871067

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Perspective Therapeutics, Inc. completed the acquisition of Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc.
Perspective Therapeutics, Inc. entered into an asset purchase agreement to acquire Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc. for $8 million.
International Isotopes Inc. Terminates Manufacturing and Supply Agreement with Progenics Pharmaceuticals, Inc
Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc., and Exini Diagnostics AB Announces U.S. Food and Drug Administration Clearance for Ai-Enabled Automated Bone Scan Index in Prostate Cancer on GE Healthcare’S Xeleris Platform
PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
Progenics Pharmaceuticals, Inc. Announces Board Changes
Progenics Pharmaceuticals, Inc. Announces Executive Changes
Progenics Pharmaceuticals, Inc. Announces Executive Changes
Progenics Pharmaceuticals, Inc. Appoints Robert J. Marshall Jr. as Treasurer
Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Composite 1500
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 1000
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P TMI Index
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Global BMI Index
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600 Health Care
Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Biotechnology Select Industry Index
Lantheus Holdings, Inc. completed the acquisition of Progenics Pharmaceuticals, Inc. from Velan Capital, L.P., Virinder Nohria, LTE Partners, LLC, Terence Cooke, Gérard Ber and others.
PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 910678 Aktie
  4. Nachrichten Progenics Pharmaceuticals, Inc.
  5. Andere Sprachen